Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis launches Ilaris in the UK

January 12, 2010
Sales and Marketing Ilaris, Novartis, cryopyrin-associated periodic syndrome

Novartis has launched its new biologic Ilaris in the UK as a treatment for cryopyrin-associated periodic syndrome. The rare debilitating …

News

ScopeMedical appoints new medical writer and boosts project team

January 12, 2010
Medical Communications ScopeMedical, appointment, medical communications

ScopeMedical has appointed Matthew Booth as a senior medical writer. Matt has nearly 10 years of solid experience within academia …

Appointment

Rexam shuts down US pharma packaging plant

January 12, 2010
Manufacturing and Production Rexam, packaging

Packaging giant Rexam has said it will close its healthcare packaging plant in Nashua, New Hampshire, before the end of …

News
FDA’s Deputy Commissioner for International Programs Murray Lumpkin

Transatlantic conversations

January 11, 2010
Research and Development EMA, FDA

The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …

Feature

Michael Moore, chairman, Oxford BioTherapeutics

January 11, 2010
Research and Development Oxford Biotherapeutics, Piramed, appointment, research and development

Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …

Appointment

FDA approves Roche’s Actemra

January 11, 2010
Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis

Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …

News
Laboratories at Loughborough University

New regenerative medicine manufacturing centre to be established in UK

January 11, 2010
Manufacturing and Production Loughborough, regenerative medicine

A new specialist centre for manufacturing in regenerative medicine is to be set up in the UK with government funding. …

News

Roche signs genetic chemistry technology deal

January 11, 2010
Research and Development Evolva, Roche, genetic chemistry

Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …

News

Alison Clough promoted to commercial and communications director for the ABPI

January 11, 2010
Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …

Appointment

Marksans presses on with plan to exit API business

January 11, 2010
Manufacturing and Production, Research and Development API, Marksans

India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …

News
Shire's ADHD website

Digital Pharma: Byte-sized roundup

January 8, 2010
Medical Communications Diabetes UK, NICE, Shire, ViiV, digital pharma, doctors.net, iphone

Includes online petition against NICE decision, Shire brings ADHD to Twitter, ViiV joins Twitter, Doctors.net.uk launches iPhone app and Diabetes …

News

NICE says no to Multaq

January 8, 2010
Sales and Marketing Multaq, NICE, Sanofi

NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …

News
b-angelici-72dpi

AstraZeneca’s Bruno Angelici awarded Légion d`honneur

January 8, 2010
Sales and Marketing AstraZeneca, France, appointment, sales and marketing

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …

Appointment

More detail needed on Conservative NHS manifesto, says think tank

January 8, 2010
Conservatives, NHS, king's fund

The Conservative Party’s draft manifesto on the NHS has been given a cautious welcome by the King’s Fund, which says …

News
GP writing prescription

England moves forward on generic substitution

January 8, 2010
Sales and Marketing NHS, generics, substitution

The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …

News

Stephen Cutler, chief operating officer, Kendle

January 8, 2010
Research and Development Kendle, appointment, research and development

Kendle has appointed Stephen Cutler to the position of senior vice president and chief operating officer.Dr Cutler has a track …

Appointment
Eisai's manufacturing and research facility in South India

Eisai looks to India for API production

January 8, 2010
Manufacturing and Production, Research and Development Eisai, India

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …

News
Charles Gutteridge

Charles Gutteridge appointed health informatics ‘tsar’

January 7, 2010
DH, NHS, UK, appointment, informatics

The Department of Health has appointed its first national clinical director for informatics. Charles Gutteridge has been medical director at …

Appointment

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010
Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …

News

Ranbaxy scales back manufacturing presence in China

January 7, 2010
Manufacturing and Production China, Guangzhou Baiyunshan Pharmaceutical Company, HNG Chembio Pharmacy, Hong Kong New Chemic, Ranbaxy

Ranbaxy has shaken up its operations in China with the divestment of its stake a joint venture with Guangzhou Baiyunshan …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026